Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685724 · ClinicalTrials.gov registry record · NA
A Pilot SMART Design for Pathological Gamblers
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT00685724: Completed NA study, sponsored by UConn Health.
NCT00685724 is a NA study that has completed, run by UConn Health. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00685724, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with only minimal interventions. In this initial study of a SMART design for pathological gamblers, we will offer a brief intervention to all (n = 100), and subsequently randomize individuals based upon their initial treatment response to varying intensities of additional care from none to 8 sessions of individual cognitive behavioral therapy (CBT) plus 14 weeks of Aftercare. Gambling outcomes will be assessed pre-treatment and at about weeks 10, 24, 36 and 52.
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy (CBT)
- BEHAVIORAL Motivational Enhancement Therapy (MET)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2008-01 |
| Est. Completion | 2011-03 |
| Phase | NA |
What the finished NCT00685724 record still lists
NCT00685724 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive-Behavioral Therapy (CBT) is the first listed.
NCT00685724 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00685724 about?
NCT00685724 is a clinical study titled "A Pilot SMART Design for Pathological Gamblers". Pathological gambling is serious problem, with significant psychological, financial, and public health consequences. Nevertheless, controlled trials examining the efficacy of therapeutic interventions for pathological gamblers are sparse, and many pathological gamblers recover on their own, or with ...
What is the current status of trial NCT00685724?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2008-01. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00685724?
The interventions under investigation include: Cognitive-Behavioral Therapy (CBT) (BEHAVIORAL), Motivational Enhancement Therapy (MET) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00685724?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00685724's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia